110 related articles for article (PubMed ID: 11360682)
1. Genetic polymorphism of CYP2D6 in Karnataka and Andhra Pradesh population in India.
Abraham BK; Adithan C; Kiran PU; Asad M; Koumaravelou K
Acta Pharmacol Sin; 2000 Jun; 21(6):494-8. PubMed ID: 11360682
[TBL] [Abstract][Full Text] [Related]
2. Polymorphism of dextromethorphan oxidation in Polish population.
Skretkowicz J; Wojtczak A; Rychlik-Sych M
Acta Pol Pharm; 2008; 65(5):611-5. PubMed ID: 19051610
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism of dextromethorphan oxidation in South Indian subjects.
Mamidi RN; Satyavageeswaran S; Vakkalanka SV; Chaluvadi MR; Katneni K; Brahmadevara N; Damodarram G; Subramaniam S
Clin Pharmacol Ther; 1999 Aug; 66(2):193-200. PubMed ID: 10460073
[TBL] [Abstract][Full Text] [Related]
4. Serum dextromethorphan/dextrorphan metabolic ratio for CYP2D6 phenotyping in clinical practice.
Jurica J; Bartecek R; Zourkova A; Pindurova E; Sulcova A; Kasparek T; Zendulka O
J Clin Pharm Ther; 2012 Aug; 37(4):486-90. PubMed ID: 22548589
[TBL] [Abstract][Full Text] [Related]
5. CYP2D6 phenotyping with dextromethorphan.
Wojtczak A; Rychlik-Sych M; Krochmalska-Ulacha E; Skretkowicz J
Pharmacol Rep; 2007; 59(6):734-8. PubMed ID: 18195464
[TBL] [Abstract][Full Text] [Related]
6. The effect of CYP2D6 polymorphisms on dextromethorphan metabolism in Mexican Americans.
Casner PR
J Clin Pharmacol; 2005 Nov; 45(11):1230-5. PubMed ID: 16239355
[TBL] [Abstract][Full Text] [Related]
7. Effect of low-dose ritonavir (100 mg twice daily) on the activity of cytochrome P450 2D6 in healthy volunteers.
Aarnoutse RE; Kleinnijenhuis J; Koopmans PP; Touw DJ; Wieling J; Hekster YA; Burger DM
Clin Pharmacol Ther; 2005 Dec; 78(6):664-74. PubMed ID: 16338282
[TBL] [Abstract][Full Text] [Related]
8. Novel single-point plasma or saliva dextromethorphan method for determining CYP2D6 activity.
Hu OY; Tang HS; Lane HY; Chang WH; Hu TM
J Pharmacol Exp Ther; 1998 Jun; 285(3):955-60. PubMed ID: 9618394
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and polymorphic oxidation of dextromethorphan in a Japanese population.
Nagai N; Kawakubo T; Kaneko F; Ishii M; Shinohara R; Saito Y; Shimamura H; Ohnishi A; Ogata H
Biopharm Drug Dispos; 1996 Jul; 17(5):421-33. PubMed ID: 8830977
[TBL] [Abstract][Full Text] [Related]
10. Dose dependency of dextromethorphan for cytochrome P450 2D6 (CYP2D6) phenotyping.
Streetman DS; Ellis RE; Nafziger AN; Leeder JS; Gaedigk A; Gotschall R; Kearns GL; Bertino JS
Clin Pharmacol Ther; 1999 Nov; 66(5):535-41. PubMed ID: 10579482
[TBL] [Abstract][Full Text] [Related]
11. [Correlation of genetic polymorphism of cytochrome P4502D6 with dextromethorphan oxidative metabolism in Chinese].
Cai W; Chen B; Tao X; Ling S; Zhang Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Jun; 17(3):181-4. PubMed ID: 10837520
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P
Dhuya M; Pal MM; Hazra A; Chatterjee S; Gogtay N
Indian J Pharmacol; 2020; 52(3):189-195. PubMed ID: 32874001
[TBL] [Abstract][Full Text] [Related]
13. CYP2D6 genotype and phenotype in Amerindians of Tepehuano origin and Mestizos of Durango, Mexico.
Sosa-Macías M; Elizondo G; Flores-Pérez C; Flores-Pérez J; Bradley-Alvarez F; Alanis-Bañuelos RE; Lares-Asseff I
J Clin Pharmacol; 2006 May; 46(5):527-36. PubMed ID: 16638736
[TBL] [Abstract][Full Text] [Related]
14. Assessment of in vivo CYP2D6 activity: differential sensitivity of commonly used probes to urine pH.
Ozdemir M; Crewe KH; Tucker GT; Rostami-Hodjegan A
J Clin Pharmacol; 2004 Dec; 44(12):1398-404. PubMed ID: 15545311
[TBL] [Abstract][Full Text] [Related]
15. Dextromethorphan to dextrorphan urinary metabolic ratio does not reflect dextromethorphan oral clearance.
Borges S; Li L; Hamman MA; Jones DR; Hall SD; Gorski JC
Drug Metab Dispos; 2005 Jul; 33(7):1052-5. PubMed ID: 15821042
[TBL] [Abstract][Full Text] [Related]
16. The AmpliChip CYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction.
Rebsamen MC; Desmeules J; Daali Y; Chiappe A; Diemand A; Rey C; Chabert J; Dayer P; Hochstrasser D; Rossier MF
Pharmacogenomics J; 2009 Feb; 9(1):34-41. PubMed ID: 18591960
[TBL] [Abstract][Full Text] [Related]
17. Influence of CYP2D6 deletion, multiplication, -1584C-->G, 31G-->A and 2988G-->a gene polymorphisms on dextromethorphan metabolism among Mexican tepehuanos and mestizos.
Sosa-Macías M; Dorado P; Alanis-Bañuelos RE; Llerena A; Lares-Asseff I
Pharmacology; 2010; 86(1):30-6. PubMed ID: 20588073
[TBL] [Abstract][Full Text] [Related]
18. Drug extrapyramidal side-effects or not: is there a dextromethorphan phenotype difference?
Vandel P; Haffen E; Vandel S; Bonin B; Sechter D; Bizouard P; Dalery J
Therapie; 2000; 55(3):349-53. PubMed ID: 10967711
[TBL] [Abstract][Full Text] [Related]
19. CYP2D6-related oxidation polymorphism in a Canadian Inuit population.
Jurima-Romet M; Foster BC; Casley WL; Rode A; Vloshinsky P; Huang HS; Geertsen S
Can J Physiol Pharmacol; 1997 Mar; 75(3):165-72. PubMed ID: 9164697
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of cytochrome P450 2D6 phenotyping in healthy adult Western Indians.
Gogtay NJ; Mali NB; Iyer K; Kadam PP; Sridharan K; Shrimal D; Thatte UM
Indian J Pharmacol; 2014; 46(3):266-9. PubMed ID: 24987171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]